On September 1, 2021 Bicycle Therapeutics plc (NASDAQ: BCYC), a biotechnology company pioneering a new and differentiated class of therapeutics based on its proprietary bicyclic peptide (Bicycle) technology, reported that management will participate in the following investor conferences in September (Press release, Bicycle Therapeutics, SEP 1, 2021, View Source [SID1234587101]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Goldman Sachs Eleventh Annual Biotech Symposium on Tuesday, September 7, 2021
H.C. Wainwright 23rd Annual Global Investment Conference on Monday, September 13, 2021; pre-recorded presentation available on demand at 7:00 a.m. ET
Morgan Stanley 19th Annual Global Healthcare Conference on Tuesday, September 14, 2021
Cantor Virtual Global Healthcare Conference on Monday, September 27, 2021; fireside chat at 11:20 a.m. ET
A live webcast of the fireside chats and replay of the pre-recorded presentation will be accessible in the Investors & Media section of Bicycle’s website at www.bicycletherapeutics.com. Archived replays of the webcasts will be available for 30 days following the pre-recorded presentation and fireside chat dates.

On September 1, 2021 Arcus Biosciences, Inc. (NYSE:RCUS), an oncology-focused biopharmaceutical company working to create best-in-class cancer therapies, reported that management will present at the following upcoming September 2021 virtual investor conferences (Press release, Arcus Biosciences, SEP 1, 2021, View Source [SID1234587121]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Citi’s 16th Annual Virtual Biopharma Conference, Friday, September 10 at 1:25 pm ET
2021 Cantor Virtual Global Healthcare Conference, Monday, September 27 at 4:40 pm ET
A live audio webcast of the presentation will be available by visiting the "Investors" section of the Arcus website at www.arcusbio.com. A replay of the webcast will be available for at least two weeks following the live event.

On September 1, 2021 Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health" or the "Company") reported that the Company will participate in multiple upcoming investor conferences (Press release, Bausch Health, SEP 1, 2021, View Source [SID1234587140]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Sam Eldessouky, executive vice president and chief financial officer; William Woodfield, senior vice president and treasurer; and Arthur J. Shannon, senior vice president and head of Investor Relations and Communications, are scheduled to participate at the J.P. Morgan European High Yield & Leveraged Finance Conference on Sept. 9, 2021 and the Deutsche Bank 29th Annual Leveraged Finance Conference on Oct. 4, 2021 at 11:00 a.m. ET.

Joseph C. Papa, chairman and chief executive officer; Sam Eldessouky, executive vice president and chief financial officer; and Arthur J. Shannon, senior vice president and head of Investor Relations and Communications, are scheduled to participate at the Morgan Stanley Global Healthcare Conference 2021 on Sept. 13, 2021 at 11:00 a.m. ET.

Live webcasts and audio archives of the September 13 and October 4 events will be available on the Investor Relations page of the Bausch Health Companies Inc. website at: View Source

On September 1, 2021 Exact Sciences Corp. (Nasdaq: EXAS) reported that company management will participate in the following virtual conferences and invited investors to participate by webcast (Press release, Exact Sciences, SEP 1, 2021, View Source [SID1234587085]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Wells Fargo Virtual Healthcare Conference
Fireside Chat on Thursday, September 9, 2021 at 10:40 a.m. EDT

Baird 2021 Global Healthcare Conference
Fireside Chat on Wednesday, September 15, 2021 at 12:15 p.m. EDT
The webcasts can be accessed in the investor relations section of Exact Sciences’ website at www.exactsciences.com.

On September 1, 2021 Arvinas, Inc. (Nasdaq: ARVN), a clinical-stage biotechnology company creating a new class of drugs based on targeted protein degradation, reported that it will participate in two upcoming virtual investor conferences (Press release, Arvinas, SEP 1, 2021, View Source [SID1234587102]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Citi 16th Annual BioPharma Virtual Conference on Thursday, September 9, 2021. John Houston, Ph.D., President and Chief Executive Officer, and Ron Peck, M.D., Chief Medical Officer, will participate in a fireside chat at 9:45 a.m. ET. A live audio webcast of the presentation will be available here and on the Events + Presentations section of the Company’s website.

2021 Cantor Virtual Global Healthcare Conference on Tuesday, September 28, 2021. Sean Cassidy, Chief Financial Officer, and Ian Taylor, Ph.D., Chief Scientific Officer, will participate in a fireside chat at 9:20 a.m. ET. A live audio webcast of the presentation will be available here and on the Events + Presentations section of the Company’s website.